Evaluation of bone repair after the installation of functionalized implants with anabolic medication associated with systemic administration of antiresorptive in rats with estrogen deficiency and metabolic syndrome

Author(s)

Ana Cláudia Ervolino da Silva

• Document type: Master's Dissertation
• Press: Araçatuba. 2021-02-20.
• Institution: Universidade Estadual Paulista (Unesp). Faculdade de Odontologia. Araçatuba
• Defense date: 2021-02-11
• Advisor: Roberta Okamoto; Luana Marotta Reis de Vasconcellos

Abstract

The objective of this study was to investigate the action of the association of systemic medication (oral biphosphonate) and teriparatide as local medication functionalized to the surfaces of implants. For the execution of this project, it was divided in 2 stages. The first stage consisted in determining the best protocol for the functionalization of implants with teriparatide, based on the layer by layer technique. Still in this stage, physical and in vitro tests (cell cultures) were performed in order to evaluate the properties of the functionalized surface, regarding the improvement in osteogenic responses. The second stage consisted in conducting in vivo experiments to evaluate the effect of this surface functionalized during the periimplant repair. For this, 96 Wistar rats, young adults were divided into six large groups: 1. SHAM Group (n=16), where the animals underwent sham surgery and balanced diet. 2. SHAM/SM Group (n=16), in which the animals received a cafeteria diet. 3) Group OVX (n=16), in which the animals underwent ovariectomy without drug treatment. 4. Group OVX/SM (n=16), in which the animals underwent ovariectomy and received a cafeteria diet. 5. Group OVX/SM/RIS (n=16), in which the animals underwent ovariectomy surgery and cafeteria diet associated with drug treatment with sodium risedronate. 6. Group OVX/RIS (n=16), in which the animals underwent ovariectomy and were treated with sodium risedronate. In each large group there are two subgroups: A- conventional implants and B- implants functionalized with teriparatide. After 30 days of beginning the drug treatment, the animals were submitted to bilateral first molar exodontia, then received the implants in the region where the exodontia was performed. At 28 days after installation of the implants, the animals were euthanized to measure the removal torque. The data were submitted to the homoscedasticity test (Shapiro Wilk). There was confirmation of normal distribution of the sample data and in the sequence, the parametric test ANOVA One Way was performed, followed by Tukey's post-test, with the significance level of 5% (p<0.05). The functionalized implants had the highest removal torque values in all experimental groups. The systemic association between sodium risedronate and teriparatide topically resulted in the OVX/SM/RIS teriparatide group obtaining the highest removal torque when compared to the other groups. Thus, it is concluded that the clinical performance of implants functionalized with teriparatida was favorable, however, when associated with systemic administration of sodium risedronate, the results become more promising. (AU)

• FAPESP's process: 19/09946-0 - Evaluation of bone repair after the installation of functionalized implants with anabolic medication associated with systemic administration of antiresorptive in estrogen deficient rats and metabolic syndrome
• Grantee: Ana Cláudia Ervolino da Silva
• Support Opportunities: Scholarships in Brazil - Master